These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Do the benefits of currently available treatments justify early diagnosis and treatment of amyotrophic lateral sclerosis? Arguments against. Ludolph AC, Riepe MW. Neurology; 1999; 53(8 Suppl 5):S46-9; discussion S55-7. PubMed ID: 10560638 [Abstract] [Full Text] [Related]
6. Nortriptyline delays disease onset in models of chronic neurodegeneration. Wang H, Guan Y, Wang X, Smith K, Cormier K, Zhu S, Stavrovskaya IG, Huo C, Ferrante RJ, Kristal BS, Friedlander RM. Eur J Neurosci; 2007 Aug; 26(3):633-41. PubMed ID: 17686041 [Abstract] [Full Text] [Related]
17. Axon guidance proteins: novel therapeutic targets for ALS? Schmidt ER, Pasterkamp RJ, van den Berg LH. Prog Neurobiol; 2009 Aug; 88(4):286-301. PubMed ID: 19523502 [Abstract] [Full Text] [Related]
18. Drug therapy for amyotrophic lateral sclerosis: Where are we now? Carter GT, Krivickas LS, Weydt P, Weiss MD, Miller RG. IDrugs; 2003 Feb; 6(2):147-53. PubMed ID: 12789618 [Abstract] [Full Text] [Related]
19. Mitochondrial alterations in dorsal root ganglion cells in sporadic amyotrophic lateral sclerosis. Sasaki S, Horie Y, Iwata M. Acta Neuropathol; 2007 Dec; 114(6):633-9. PubMed ID: 17929040 [Abstract] [Full Text] [Related]